Research graph

References

References from Comparison of Warrick Scoring and Goh Staging for Detecting Progression in Systemic Sclerosis–Associated Interstitial Lung Disease. Local targets link to admitted publications; unresolved targets remain external evidence.

10.1164/rccm.200706-877oc

10.1164/rccm.200706-877oc · External reference

10.1136/ard.2006.066068

10.1136/ard.2006.066068 · External reference

Prevalence of the limited vs. extensive scleroderma-related interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria: systematic review and meta-analysis

10.1016/j.rce.2024.02.002 · 2024 · External reference

10.1136/annrheumdis-2020-217455

10.1136/annrheumdis-2020-217455 · External reference

Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease

10.1164/rccm.201903-0563ci · 2020 · External reference

10.1164/ajrccm/148.4_pt_1.1076

10.1164/ajrccm/148.4_pt_1.1076 · External reference

10.1148/radiol.2322031223

10.1148/radiol.2322031223 · External reference

CT evaluation of interstitial lung disease related to systemic sclerosis: visual versus automated assessment. A systematic review

10.1016/j.crad.2023.11.022 · 2024 · External reference

High resolution computed tomography in early scleroderma lung disease

1991 · External reference

10.2214/ajr.169.4.9308447

10.2214/ajr.169.4.9308447 · External reference

Warrick score in rheumatoid-arthritis interstitial lung disease: a promising tool for assessing the extent and progression of lung involvement

10.1186/s42358-025-00435-w · 2025 · External reference

Clinical assessment for pulmonary hypertension in interstitial lung disease

10.1111/imj.15887 · 2023 · External reference

10.1093/rheumatology/kes289

10.1093/rheumatology/kes289 · External reference

10.1056/nejmoa055120

10.1056/nejmoa055120 · External reference

10.1056/nejmoa1903076

10.1056/nejmoa1903076 · External reference

10.1056/nejmoa2503643

10.1056/nejmoa2503643 · External reference

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

10.1016/s2213-2600(20)30318-0 · 2020 · External reference

10.1002/art.38098

10.1002/art.38098 · External reference

10.1148/radiol.2462070712

10.1148/radiol.2462070712 · External reference

[Lung fibrosis quantified by HRCT in scleroderma patients with different disease forms and ANA specificities]

2001 · External reference

Relation of Warrick score and polysomnographic parameters in patients with interstitial lung disease

10.12659/msm.914905 · 2019 · External reference